PACS Group (NYSE:PACS) Now Covered by Oppenheimer

Research analysts at Oppenheimer began coverage on shares of PACS Group (NYSE:PACS) in a report issued on Monday, MarketBeat.com reports. The brokerage set an “outperform” rating and a $31.00 price target on the stock. Oppenheimer’s price objective would indicate a potential upside of 24.05% from the company’s previous close.

Several other brokerages have also recently issued reports on PACS. Truist Financial started coverage on PACS Group in a report on Monday. They issued a “buy” rating and a $32.00 target price for the company. Royal Bank of Canada started coverage on PACS Group in a report on Monday. They set an “outperform” rating and a $30.00 price target for the company. Six research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $30.50.

PACS Group Trading Up 0.2 %

Shares of NYSE:PACS opened at $24.99 on Monday. PACS Group has a 52-week low of $22.61 and a 52-week high of $25.72.

Insider Transactions at PACS Group

In related news, CEO Jason Hulse Murray sold 1,607,142 shares of the stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $21.00, for a total transaction of $33,749,982.00. Following the transaction, the chief executive officer now owns 62,754,551 shares of the company’s stock, valued at approximately $1,317,845,571. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

PACS Group Company Profile

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.